Cargando…

Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants

SUMMARY OF STUDY: A multi-country randomized, placebo-controlled trial of the safety, immunogenicity and efficacy of respiratory syncytial virus (RSV) F-protein nanoparticle vaccine was undertaken in 4,636 pregnant women and their infants. RSV F-protein vaccine was safe and immunogenic in the pregna...

Descripción completa

Detalles Bibliográficos
Autores principales: Madhi, Shabir A, Polack, Fernando P, Piedra, Pedro A, Munoz, Flor M, Trenholme, Adrian A, Simoes, Eric AF, Swamy, Geeta K, Ahmed, Khatija, Baqui, Abdullah H, Calvert, Anna, Cotton, Mark F, Cutland, Clare L, Englund, Janet A, Gonik, Bernard, Hammitt, Laura, Heath, Paul T, de Jesus, Joanne N, Jones, Christine E, Khalil, Asma, Kimberlin, David W, Libster, Romina, Lucero, Marilla, Llapur, Conrado J, Pérez Marc, Gonzalo, Marshall, Helen S, Martinón-Torres, Federico, Nolan, Terry M, Osman, Ayman, Perret, Kirsten P, Richmond, Peter C, Snape, Matthew D, Shakib, Julie H, Stoney, Tanya, Tita, Alan T, Varner, Michael W, Vatish, Manu, Vrbicky, Keith, Zaman, Khalequ, Zar, Heather J, Meece, Jennifer K, Plested, Joyce S, Agrawal, Sapeckshita, Cho, Iksung, Chen, Janice, Thomas, D. Nigel, Wen, Judy, Fix, Amy, August, Allison, Shinde, Vivek, Glenn, Gregory M., Fries, Louis F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299433/
https://www.ncbi.nlm.nih.gov/pubmed/32726529
http://dx.doi.org/10.1056/NEJMoa1908380